SESSION III SCHEDULE
Wednesday
SESSION III: PART 1: NEW CONCEPTS IN WOUND CARE
PART 2: CLASSIC VERSUS MODERN WOUND CARE
PART 3: WOUND HEALING SOCIETIES
Moderators:Gary W. Gibbons, M.D. / David L. Steed, M.D.
x
1:00 PM - 1:05 PM Opening Remarks
  Presenters(s): Dieter O. Mayer, M.D.  
PART 1: NEW CONCEPTS IN WOUND CARE
1:07 PM - 1:15 PM The Concept Of Wound Bed Preparation
  Presenters(s): R. Gary Sibbald, M.D.  
1:15 PM - 1:23 PM The TIME Concept
  Presenters(s): Gregory Schultz, Ph.D.  
1:23 PM - 1:33 PM Panel Discussion
1:33 PM - 1:41 PM New Concepts Of Pain Management In Ulcer Patients
  Presenters(s): E. Sebastian Debus, M.D.  
1:41 PM - 1:46 PM Discussion
1:46 PM - 1:54 PM 3 D Measurement Of Wound Healing
  Presenters(s): Dieter O. Mayer, M.D.  
1:54 PM - 1:59 PM Discussion
1:59 PM - 2:07 PM Wound Antisepsis: Consensus Paper Of German Speaking Countries
  Presenters(s): Anneke Andriessen, M.D., M.A., Ph.D.  
2:07 PM - 2:12 PM Discussion
PART 2: CLASSIC VERSUS MODERN WOUND CARE
Moderator(s): Gary W. Gibbons, M.D. / Dieter O. Mayer, M.D. / Bauer E. Sumpio, M.D., Ph.D.  
2:14 PM - 2:22 PM Debate: Classic Wound Care Is Still The Best
  Presenters(s): Martin C. Robson, M.D.  
2:22 PM - 2:30 PM Debate: Modern Wound Care Is More Effective
  Presenters(s): Michael G. Franz, M.D.  
2:30 PM - 2:38 PM What Is Evidence-Based In Modern Wound Care?
  Presenters(s): David L. Steed, M.D.  
2:38 PM - 2:48 PM Panel Discussion
PART 3: WOUND HEALING SOCIETIES
2:50 PM - 3:00 PM Introducing The World Union of Wound Healing Societies
  Presenters(s): R. Gary Sibbald, M.D.  
3:00 PM - 3:20 PM Session Break / Visit Exhibits
END OF SESSION III
 
SESSION II SCHEDULE
Wednesday
SESSION II: PART 2: HEMODIALYSIS ACCESS
Moderators:Larry A. Scher, M.D. / Thomas M. Vesely, M.D.
x
PART 2A: AV FISTULAS, TRANSPOSITIONS AND GRAFTS
1:00 PM - 1:05 PM Introduction
  Presenters(s): Larry A. Scher, M.D.  
1:06 PM - 1:11 PM Why We Need A Vascular Access Society
  Presenters(s): A. Frederick Schild, M.D.  
1:12 PM - 1:24 PM 2006 K/DOQI Guideline Changes
  Presenters(s): Mitchell Henry, M.D.  
1:25 PM - 1:37 PM Surgical Methods To Maximize Fistula Creation
  Presenters(s): Surendra Shenoy, M.D., Ph.D.  
1:38 PM - 1:50 PM Surgical Management Of The Non-Maturing AV Fistula
  Presenters(s): John R. Ross, Sr., M.D.  
1:51 PM - 2:03 PM Outcomes Of Transposed AV Fistulas
  Presenters(s): Alik Farber, M.D.  
2:04 PM - 2:16 PM Vascular Access Centers
  Presenters(s): James F. McGuckin, M.D.  
2:17 PM - 2:40 PM Panel Discussion
2:40 PM - 3:05 PM Keynote Address: Early History Of AV Access For Hemodialysis
  Presenters(s): James E. Cimino, M.D.  
3:06 PM - 3:25 PM Refreshment Break
PART 2B: MISCELLANEOUS TOPICS IN VASCULAR ACCESS
Moderator(s): Thomas M. Vesely, M.D. / Larry A. Scher, M.D.  
3:26 PM - 3:38 PM Use Of Anastomotic Devices For Hemodialysis Access
  Presenters(s): Duane Blatter, M.D.  
3:39 PM - 3:51 PM Molecular Therapy For Hemodialysis Access
  Presenters(s): Jeffrey H. Lawson, M.D., Ph.D.  
3:52 PM - 4:04 PM Ischemic Complications Of Vascular Access
  Presenters(s): Samuel Eric Wilson, M.D.  
4:05 PM - 4:17 PM Educating Trainees In Vascular Access
  Presenters(s): Earl Schuman, M.D.  
4:18 PM - 4:30 PM Coding For Hemodialysis Access Surgery And Interventions
  Presenters(s): Sean P. Roddy, M.D.  
4:31 PM - 4:43 PM New Graft Materials For Hemodialysis Access
  Presenters(s): Marc H. Glickman, M.D.  
4:44 PM - 5:00 PM Panel Discussion
END OF SESSION II
 
SESSION I SCHEDULE
Wednesday
SESSION I: PART 1: HEMODIALYSIS ACCESS
Moderators:Larry A. Scher, M.D. / A. Frederick Schild, M.D.
x
10:30 AM - 10:40 AM Preventing Contrast-Induced Nephropathy: A New Tool For An Old Problem
  Presenters(s): John H. Rundback, M.D., F.S.I.R., F.A.H.A.  
10:40 AM - 10:50 AM Endovascular Management Of The Non-Maturing Fistula
  Presenters(s): Thomas M. Vesely, M.D.  
10:50 AM - 11:00 AM Percutaneous Management Of The Thrombosed Fistula
  Presenters(s): Mark J. Sands, M.D.  
11:00 AM - 11:10 AM Percutaneous Management Of The Thrombosed Graft
  Presenters(s): Jacob Cynamon, M.D.  
11:10 AM - 11:20 AM Management Of Peripheral Venous Stenoses: High Pressure Balloons, Cutting Balloons, Stents Or Stent-Grafts?
  Presenters(s): Ziv J. Haskal, M.D.  
11:20 AM - 11:30 AM Management Of Central Venous Stenoses/Occlusions
  Presenters(s): Bart L. Dolmatch, M.D.  
11:30 AM - 11:40 AM Use Of Stent-Grafts For The Management Of Hemodialysis Graft Related Pseudoaneurysms
  Presenters(s): Thomas M. Vesely, M.D.  
11:40 AM - 11:50 AM Utility Of The Angioflow Catheter
  Presenters(s): Mark J. Sands, M.D.  
11:50 AM - 12:00 PM New Developments In Hemodialysis Catheter Technology
  Presenters(s): Thomas M. Vesely, M.D.  
12:00 PM - 12:10 PM Outpatient Intervention: Not Just For Dialysis And Venous Intervention
  Presenters(s): William H. Julien, M.D.  
12:10 PM - 12:30 PM Panel Discussion
12:30 PM - 1:00 PM Lunch Break
END OF SESSION I
 
SESSION IV SCHEDULE
Wednesday
SESSION IV: PART 1: SILVER IN WOUND CARE - THE MAGIC BULLET?
PART 2: ECONOMY IN WOUND CARE
PART 3: THE DIABETIC FOOT
Moderators:Dieter O. Mayer, M.D. / David L. Steed, M.D. / Steven R. Kravitz, D.P.M.
x
PART 1: SILVER IN WOUND CARE - THE MAGIC BULLET?
3:22 PM - 3:30 PM Debate: All Forms Of Silver Are Equal
  Presenters(s): Liza G. Ovington, Ph.D., C.W.S.  
3:30 PM - 3:38 PM Debate: All Forms Of Silver Are Not Equal
  Presenters(s): Robert E. Burrell, Ph.D.  
3:38 PM - 3:48 PM Panel Discussion
3:48 PM - 3:56 PM Is Silver Effective In The Presence Of Biofilms?
  Presenters(s): J. Barry Wright, Ph.D.  
3:56 PM - 4:04 PM Has Silver Affected The Threat Of MRSA?
  Presenters(s): Robert Strohal, M.D.  
4:04 PM - 4:12 PM Is Silver Resistance An Issue In Wound Care?
  Presenters(s): Steven Percival, Ph.D., MSc, MSc PhD, FIBMS  
4:12 PM - 4:22 PM Panel Discussion
PART 2: ECONOMY IN WOUND CARE
Moderator(s): Gary W. Gibbons, M.D. / David L. Steed, M.D.  
4:24 PM - 4:32 PM Debate: Modern Wound Therapy Does Contribute To The Cost Explosion
  Presenters(s): Michael S. Weingarten, M.D.  
4:32 PM - 4:40 PM Debate: Modern Wound Therapy Does Not Contribute To The Cost Explosion
  Presenters(s): Robert E. Burrell, Ph.D.  
4:40 PM - 4:48 PM How To Bill For Wound Care After Vascular Surgery
  Presenters(s): Christopher E. Attinger, M.D.  
4:48 PM - 4:58 PM Panel Discussion
PART 3: THE DIABETIC FOOT
Moderator(s): Dieter O. Mayer, M.D. / David L. Steed, M.D. / Peter A. Blume, D.P.M., F.A.C.S.  
5:00 PM - 5:08 PM Debate: Osteomyelitis: There Is An Absolute Need For Radical Resection
  Presenters(s): Gary W. Gibbons, M.D.  
5:08 PM - 5:16 PM Debate: Osteomyelitis: There Is Not An Absolute Need For Radical Resection
  Presenters(s): Thomas Boeni, M.D.  
5:16 PM - 5:26 PM Panel Discussion
5:26 PM - 5:34 PM VAC: The Ideal Tool For Diabetic Foot Ulcers
  Presenters(s): David G. Armstrong, D.P.M., Ph.D.  
5:34 PM - 5:42 PM HBO: Value In Nonhealing Diabetic Foot Ulcers
  Presenters(s): Palma M. Shaw, M.D.  
5:42 PM - 5:52 PM Panel Discussion
5:52 PM - 6:00 PM Closing Remarks
Gary W. Gibbons, M.D. and
David L. Steed, M.D.
END OF SESSION IV
 
SESSION V SCHEDULE
Wednesday
SESSION V: PART 1: ENDOVENOUS TREATMENT OF VARICOSE VEINS (8-MINUTE TALKS)
Moderators:Jose I. Almeida, M.D., F.A.C.S., R.V.T. / Lowell S. Kabnick, M.D., F.A.C.S.
x
1:00 PM - 1:08 PM Anatomy And Patterns Of Reflux In The GSV And Accessory Saphenous Vein
  Presenters(s): Robert J. Min, M.D., M.B.A.  
1:08 PM - 1:16 PM Anatomy And Patterns Of Reflux In The Small Saphenous Vein
  Presenters(s): Neil M. Khilnani, M.D.  
1:16 PM - 1:24 PM Debate: Open Surgery Is Still The Best Technique To Ablate The Great Saphenous Vein
  Presenters(s): Alun H. Davies, M.A., D.M., F.R.C.S.  
1:24 PM - 1:32 PM Debate: Only Troglodytes Perform Open Surgery For Varicose Vein Treatment: Here’s Why
  Presenters(s): Jose I. Almeida, M.D., F.A.C.S., R.V.T.  
1:32 PM - 1:40 PM Radiofrequency Ablation Of The GSV: 5-Year Data
  Presenters(s): Alan M. Dietzek, M.D., F.A.C.S., R.P.V.I.  
1:40 PM - 1:48 PM Laser Ablation Of The GSV: 5-Year Data
  Presenters(s): Robert J. Min, M.D., M.B.A.  
1:48 PM - 2:04 PM Panel Discussion
2:04 PM - 2:12 PM ClosureFAST: Segmental Radiofrequency Ablation Of The GSV In Under 3 Minutes
  Presenters(s): Alan B. Lumsden, M.D., F.A.C.S.  
2:12 PM - 2:20 PM Complications Of Endovenous Therapies: Statistics And Treatment
  Presenters(s): Lowell S. Kabnick, M.D., F.A.C.S.  
2:20 PM - 2:28 PM The Swollen Limb And Compression
  Presenters(s): Joseph A. Caprini, M.D.  
2:28 PM - 2:36 PM Role Of Foam Sclerotherapy In The Management Of Varicose Veins
  Presenters(s): John J. Bergan, M.D.  
2:36 PM - 2:44 PM What Sclerotherapy Agents Are Available: How To Procure Them, And When To Use Them
  Presenters(s): Lowell S. Kabnick, M.D., F.A.C.S.  
2:44 PM - 3:00 PM Panel Discussion
Refreshments Available
END OF SESSION V
 
SESSION VI SCHEDULE
Wednesday
SESSION VI: PART 2: ENDOVENOUS TREATMENT OF VARICOSE VEINS (8-MINUTE TALKS)
Moderators:Lowell S. Kabnick, M.D., F.A.C.S. / Jose I. Almeida, M.D., F.A.C.S., R.V.T.
x
3:00 PM - 3:08 PM When To Treat Perforators And How
  Presenters(s): Peter Gloviczki, M.D.  
3:08 PM - 3:16 PM Debate: Adjunctive Procedures Should Be Performed At The Time Of Endovascular Treatment Of Valvular And Perforator Insufficiency
  Presenters(s): Jose I. Almeida, M.D., F.A.C.S., R.V.T.  
3:16 PM - 3:24 PM Debate: Adjunctive Procedures Should Not Be Performed At The Time Of Endovascular Treatment Of Valvular And Perforator Insufficiency
  Presenters(s): Lowell S. Kabnick, M.D., F.A.C.S.  
3:24 PM - 3:32 PM Role Of Venous Duplex Ultrasound: Pre-op, Intra-op, And Post-op
  Presenters(s): Neil M. Khilnani, M.D.  
3:32 PM - 3:40 PM The Role Of Fluoroscopy In The Management Of Varicose Veins
  Presenters(s): Melvin Rosenblatt, M.D.  
3:40 PM - 3:48 PM The Future Of Venous Imaging: Will It Be Duplex Ultrasound, MRV Or CTV?
  Presenters(s): Barry Stein, M.D. F.S.I.R.  
3:48 PM - 4:04 PM Panel Discussion
4:04 PM - 4:12 PM Management Of GSV In The Presence Of Thrombophilia
  Presenters(s): Joseph A. Caprini, M.D.  
4:12 PM - 4:20 PM Endovenous Treatment Of Iliac Vein Stenosis: When And How?
  Presenters(s): Mark H. Meissner, M.D.  
4:20 PM - 4:28 PM How To Build A Venous Practice
  Presenters(s): Alan M. Dietzek, M.D., F.A.C.S., R.P.V.I.  
4:28 PM - 4:36 PM Balancing The Arterial And Venous Practice: How I Do It: How Much Can Be Done Safely In The Office?
  Presenters(s): Russell H. Samson, M.D., F.A.C.S., R.V.T.  
4:36 PM - 4:44 PM What’s New With Commercial Insurance, ASC, And Medicare Concerning Venous Treatment?
  Presenters(s): Melvin Rosenblatt, M.D.  
4:44 PM - 5:00 PM Panel Discussion
END OF SESSION VI
 
SESSION VII SCHEDULE
Thursday
SESSION VII: TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D.
x
6:40 AM - 6:47 AM Is Carotid Stenting (CAS) Really Contraindicated In Patients Over 80 Years Of Age? Why Is This So?
  Presenters(s): Michel S. Makaroun, M.D.  
6:48 AM - 6:55 AM Technical Tips For Performing CAS Safely: Which Patients Should Get Endarterectomy (CEA) Based On Angiographic And IVUS Evaluation Of Plaque Morphology?
  Presenters(s): Mark H. Wholey, M.D.  
6:56 AM - 7:03 AM Evolution Of Proximal Occlusion Embolic Protection Devices: Relative And Absolute Indications And Contraindications
  Presenters(s): Juan C. Parodi, M.D.  
7:04 AM - 7:11 AM Are Endovascular Procedures Feasible In Infants And Children? What Precautions Or Special Instrumentation Are Needed?
  Presenters(s): Michael B. Silva, Jr., M.D.  
7:12 AM - 7:19 AM Results Of Celiac And Mesenteric Stenting: Technical Tips And High Recurrence Rates
  Presenters(s): Jos C. van den Berg, M.D., Ph.D.  
7:20 AM - 7:27 AM Debate: Open AAA Repair Still Has A Major Role In Good Risk Young Patients
  Presenters(s): Robert B. Rutherford, M.D.  
7:28 AM - 7:35 AM Debate: All Good Risk AAA Patients With Suitable Anatomy Should Be Treated With EVAR
  Presenters(s): Edward B. Diethrich, M.D.  
7:36 AM - 7:45 AM Panel Discussion
END OF SESSION VII
 
SESSION VIII SCHEDULE
Thursday
SESSION VIII: MORE TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS (7-MINUTE TALKS)
Moderators:Lucien D. Castellani, M.D.
x
7:45 AM - 7:52 AM Debate: Neck Enlargement After EVAR Is Common And Has Dire Consequences
  Presenters(s): Piergiorgio Cao, M.D.  
7:53 AM - 8:00 AM Debate: Neck Enlargement After EVAR Is Rare And Benign
  Presenters(s): James May, M.D., M.S., F.R.A.C.S., F.A.C.S.  
8:01 AM - 8:08 AM Technique And Importance Of Duplex Surveillance After SFA Stenting: Does It Make A Difference?
  Presenters(s): Dennis F. Bandyk, M.D.  
8:09 AM - 8:16 AM One-Year Results Of The FAST Trial For The Treatment Of SFA Disease
  Presenters(s): Hans Krankenberg, M.D.  
8:17 AM - 8:24 AM Role Of Cutting Balloons For De Novo And Recurrent Lesions
  Presenters(s): Peter A. Schneider, M.D.  
8:25 AM - 8:34 AM Panel Discussion
END OF SESSION VIII
 
SESSION IX SCHEDULE
Thursday
SESSION IX: NEW HORIZONS AND OPPORTUNITIES FOR CARDIAC SURGEONS (7-MINUTE TALKS)
Moderators:Bruce Lytle, M.D.
x
8:35 AM - 8:42 AM Endovascular Approaches To Mitral Valve Disease
  Presenters(s): Ted Feldman, M.D.  
8:43 AM - 8:50 AM Endovascular Pulmonic Valve Replacement
  Presenters(s): Philipp Bonhoeffer, M.D.  
8:51 AM - 8:58 AM Functional Replacement For Tricuspid Insufficiency: An Endovascular Approach
  Presenters(s): Roy K. Greenberg, M.D.  
8:59 AM - 9:06 AM Experience With Percutaneous Aortic Valve Replacement: Future Potential
  Presenters(s): Martin B. Leon, M.D.  
9:07 AM - 9:14 AM Implications Of The Aortic Valve On Endovascular Repairs Of The Ascending Aorta
  Presenters(s): Timothy A.M. Chuter, M.D.  
9:15 AM - 9:22 AM Hybrid (Open/Endo) Approaches For Repair Of Ascending And Arch Aneurysms
  Presenters(s): Bruce Lytle, M.D.  
9:23 AM - 9:30 AM Debate: Endovascular Treatment Of Adult Coarctation And Its Complications: The Best Treatment For Most Patients
  Presenters(s): Christoph A. Nienaber, M.D.  
9:31 AM - 9:38 AM Debate: Current Status Of Treatment For Adult Coarctation: Open Surgery Is Still The Best Treatment For Most Patients
  Presenters(s): Joseph E. Bavaria, M.D.  
9:39 AM - 9:49 AM Panel Discussion
END OF SESSION IX
 
SESSION X SCHEDULE
Thursday
SESSION X: SUPERFICIAL FEMORAL ARTERY (SFA) AND CRURAL ARTERY TREATMENT: STATE-OF-THE-ART AND NEW ADJUNCTS (6- AND 7-MINUTE TALKS)
x
9:50 AM - 9:57 AM Natural History Of Patients With Arterial Insufficiency And Non-Healing Ulcers Treated Conservatively: How Does It Impact On Limb Salvage Results With Aggressive New Endo-Interventions And Are We Being Fooled Into Over-Treating?
  Presenters(s): Blair A. Keagy, M.D.  
9:58 AM - 10:05 AM Outcomes Of Infrainguinal Intervention: Beyond The Hype And Baloney - What Really Works And What Does Not?
  Presenters(s): Alan T. Hirsch, M.D.  
10:06 AM - 10:13 AM PTA vs. Stenting Of The SFA: Results Of The Resilient Randomized Trial
  Presenters(s): Barry T. Katzen, M.D.  
10:14 AM - 10:21 AM How To Avoid Fractures In SFA Stents And Will It Improve Results: Are Absorbable Stents The Answer?
  Presenters(s): Giancarlo Biamino, M.D.  
10:22 AM - 10:28 AM Role Of SFA Stents In 2006: How Well Do They Work?
  Presenters(s): Mark W. Mewissen, M.D.  
10:29 AM - 10:35 AM Do We Have The Right Stents For Femoropopliteal Lesions And 2-3 Year Results Of A Randomized Trial Comparing Absorbable Metal Stents To PTA Alone In Crural Arteries?
  Presenters(s): Marc Bosiers, M.D.  
10:36 AM - 10:42 AM 3-Year Trial Results Of Zilver Nitinol Stents For Long SFA Lesions (TASC C And D)
  Presenters(s): Marcelo Ferreira, M.D.  
10:43 AM - 10:49 AM Update On The Value And Limitations Of The Silverhawk Rotational Atherectomy Device For Treatment Of Infrainguinal Disease
  Presenters(s): Venkatesh G. Ramaiah, M.D.  
10:50 AM - 10:56 AM Midterm Results Of Rotational Atherectomy In Patients With TASC C Lesions Treated For Critical Ischemia
  Presenters(s): David J. Minion, M.D.  
10:57 AM - 11:03 AM Role Of Lasers In The Treatment Of Lower Extremity Occlusive Disease: Is There A Place After All?
  Presenters(s): John R. Laird, M.D.  
11:04 AM - 11:14 AM Panel Discussion
END OF SESSION X
 
SESSION XI SCHEDULE
Thursday
SESSION XI: CRITICAL LOOK AT CAROTID STENTING (CAS) (6-MINUTE TALKS)
Moderators:Kenneth Ouriel, M.D., F.A.C.S., F.A.C.C. / Frank J. Veith, M.D.
x
11:15 AM - 11:21 AM Debate: Carotid Interventions Are Justified In High Risk Asymptomatic Patients: Of Course They Are
  Presenters(s): Frank J. Criado, M.D.  
11:22 AM - 11:28 AM Debate: Why Interventions (CAS And CEA) Are Rarely Justified And Indicated In High Risk Asymptomatic Patients
  Presenters(s): Geoffrey L. Gilling-Smith, M.S., F.R.C.S.  
11:29 AM - 11:35 AM Is It Justified And Ethical To Perform CAS In Asymptomatic Patients? Will We Ever Know?
  Presenters(s): Alison Halliday, M.S., F.R.C.S.  
11:36 AM - 11:42 AM The Asymptomatic Carotid Trials: How Can The Results Be Interpreted So Differently And Should Asymptomatic Patients Really Be Treated?
  Presenters(s): A. Ross Naylor, M.D., F.R.C.S.  
11:43 AM - 11:50 AM In Asymptomatic Patients, What Is A High Risk Plaque If We Intervene? If We Treat Conservatively? What Should We Do?
  Presenters(s): Giorgio M. Biasi, M.D.  
11:51 AM - 11:57 PM Embolic Protection Devices In CAS Remain Unproven And Are Much Ado About Nothing
  Presenters(s): Emmanuel M. Houdart, M.D.  
11:58 AM - 12:04 PM Randomized Prospective Trial Of Embolic Protection Devices In CAS
  Presenters(s): Michel S. Makaroun, M.D.  
12:05 PM - 12:11 PM CAS vs. CEA In Symptomatic Carotid Stenosis Patients: Early Results Of The French Randomized Study (EVA-3S)
  Presenters(s): Jean-Pierre Becquemin, M.D., F.R.C.S.  
12:12 PM - 12:18 PM A New Technique To Reduce Guidewire Manipulation During Carotid Artery Stenting: The Superficial Temporal Artery Approach
  Presenters(s): Martin Malina, M.D., Ph.D.  
12:19 PM - 12:30 PM Panel Discussion
12:30 PM - 1:30 PM Lunch Break
END OF SESSION XI
 
SESSION XII SCHEDULE
Thursday
SESSION XII: NEW DEVELOPMENTS IN EVAR (7-MINUTE TALKS)
x
1:30 PM - 1:37 PM Debate: Fenestrated Grafts For Short-Necked AAAs Are Time Consuming, Costly And Unnecessary
  Presenters(s): Jacob Buth, M.D.  
1:38 PM - 1:45 PM Debate: Fenestrated Grafts For Short-Necked AAAs Are Easy, Effective And The Way To Go
  Presenters(s): Roy K. Greenberg, M.D.  
1:46 PM - 1:53 PM Does The Graft Make A Difference In EVAR? Which Graft Should Be Used To Deal With Short Necks? With Angulated Necks?
  Presenters(s): Dieter Raithel, M.D., Ph.D.  
1:54 PM - 2:01 PM Can EVAR Be Used Successfully In Patients With <15 mm Necks?
  Presenters(s): Neal S. Cayne, M.D.  
2:02 PM - 2:09 PM Why Do Results With EVAR For Ruptured AAAs Vary? Technical Tips, Adjuncts And Strategies To Improve These Results
  Presenters(s): Frank J. Veith, M.D.  
2:10 PM - 2:17 PM Solving The Problem Of Abdominal Compartment Syndrome After EVAR For Ruptured AAAs: Detection And Treatment
  Presenters(s): Mario Lachat, M.D.  
2:18 PM - 2:25 PM Evolution Of Optimal Methods To Follow Patients After EVAR: Several Myths Need To Be Dispelled
  Presenters(s): Jan D. Blankensteijn, M.D.  
2:26 PM - 2:34 PM Panel Discussion
END OF SESSION XII
 
SESSION XIII SCHEDULE
Thursday
SESSION XIII: OTHER TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS (7-MINUTE TALKS)
x
2:35 PM - 2:42 PM The Real Truth About Endografts For Popliteal Aneurysm Disease Based On An 8-Year Experience With More Than 70 Cases: Indications, Contraindications And Complications
  Presenters(s): Eric L.G. Verhoeven, M.D., Ph.D.  
2:43 PM - 2:50 PM The Pioneer, Frontrunner Or Outback Catheter Are Necessary Adjuncts For Crossing Occlusive Lesions
  Presenters(s): Mark W. Mewissen, M.D.  
2:51 PM - 2:58 PM Simple Techniques For Crossing Total Occlusions Of The Iliac, Femoropopliteal And Crural Arteries Without Special Devices
  Presenters(s): Ali Amin, M.D., F.A.C.S., F.A.C.C., R.V.T.  
2:59 PM - 3:06 PM Subintimal Angioplasty Of Long Occlusive Lesions Of The SFA And Tibial Arteries: Technical Tips And Midterm Results
  Presenters(s): Joseph L. Mills, M.D.  
3:07 PM - 3:14 PM Technical Tips, Tricks And Adjuncts To Improve Endovascular Treatment Of Leg Artery Lesions Causing Critical Ischemia
  Presenters(s): Max Amor, M.D.  
3:15 PM - 3:22 PM Debate: The SAPPHIRE And CAPTURE Trials Establish The Basis For Widespread Use Of Carotid Stenting (CAS)
  Presenters(s): Jay S. Yadav, M.D.  
3:23 PM - 3:30 PM Debate: The SAPPHIRE And CAPTURE Trials Are Flawed And Should Have Minimal Impact On The Expanded Use Of CAS
  Presenters(s): Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E.  
3:31 PM - 3:38 PM CAS vs. CEA In Symptomatic Carotid Stenosis Patients: Results Of The German Randomized Trial (The SPACE Trial)
  Presenters(s): Hans-Henning Eckstein, M.D., Ph.D.  
3:39 PM - 3:48 PM Panel Discussion
END OF SESSION XIII
 
SESSION XIV SCHEDULE
Thursday
SESSION XIV: PREVENTION AND MANAGEMENT OF COMPLICATIONS OF ENDOVASCULAR TREATMENTS (7-MINUTE TALKS)
Moderators:Mark A. Adelman, M.D. / Götz M. Richter, M.D., Ph.D.
x
3:49 PM - 3:56 PM What Should Be Done When A Stroke Occurs During Or After CAS?
  Presenters(s): Claudio Schonholz, M.D.  
3:57 PM - 4:04 PM How To Prevent Strokes During CAS: It’s The Details That Count
  Presenters(s): Juan C. Parodi, M.D.  
4:05 PM - 4:12 PM Is There A Role For Embolic Protection During Femoropopliteal Interventions? How Should It Be Done?
  Presenters(s): Michael H. Wholey, M.D.  
4:13 PM - 4:20 PM Update On Approved And Unapproved Uses Of The RENU Proximal Extension Device: Indications, Precautions And Results
  Presenters(s): Samuel R. Money, M.D., M.B.A.  
4:21 PM - 4:28 PM Pros And Cons Of Embolic Protection During Renal PTA And Stenting
  Presenters(s): Thomas A. Sos, M.D.  
4:29 PM - 4:36 PM Panel Discussion
END OF SESSION XIV
 
SESSION XV SCHEDULE
Thursday
SESSION XV: UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE AND ITS TREATMENT (7-MINUTE TALKS)
Moderators:Jacques Busquet, M.D. / Juan C. Parodi, M.D.
x
4:37 PM - 4:44 AM Radiation Danger To Surgeons And Interventionists During Endovascular Procedures Is Greater Than Previously Thought: What Can Be Done About It?
  Presenters(s): Gary M. Ansel, M.D.  
4:45 PM - 4:52 PM What Improvements Make Simulators More Useful For Endovascular Training In Interventions?
  Presenters(s): James R. Duncan, M.D., Ph.D.  
4:53 PM - 5:00 PM Optimal Agents For Embolic Therapy: New Developments
  Presenters(s): Götz M. Richter, M.D., Ph.D.  
5:01 PM - 5:08 PM The Next Generation Of "Safer" Drug-Eluting Stents: What Does The Future Hold?
  Presenters(s): Martin B. Leon, M.D.  
5:09 PM - 5:16 PM Highlights Of 2006 Consensus Statement On Prevention And Treatment Of Venous Thromboembolism
  Presenters(s): Andrew N. Nicolaides, M.S., F.R.C.S.  
5:17 PM - 5:24 PM Panel Discussion
Moderator(s): Patrick J. Lamparello, M.D. / Herbert Dardik, M.D.  
5:25 PM - 5:32 PM What Is The Best Treatment For Iliac Occlusive Disease? Which Lesion Should Be Ballooned, Which Stented, Which Bypassed And Which Left Alone?
  Presenters(s): Peter G. Kalman, M.D.  
5:33 PM - 5:41 PM Ultrasound Accelerated Lysis: Technique And Multicenter Experience
  Presenters(s): Thomas O. McNamara, M.D.  
5:42 PM - 5:49 PM A Stent With A Biological Covering (Peritoneum): Experimental And Early Clinical Evaluation Of A Potentially Better Device
  Presenters(s): Timur P. Sarac, M.D.  
5:50 PM - 5:57 PM Is Balloon Angioplasty Of Perianastomotic Stenoses Of Failing Leg Bypasses Worthwhile?
  Presenters(s): Keith D. Calligaro, M.D.  
5:58 PM - 6:05 PM A New Drug To Help Smokers Quit: The Role of VARENICLINE
  Presenters(s): Richard D. Hurt, M.D.  
6:06 PM - 6:13 PM What Is The Future For Bioabsorbable Stents?
  Presenters(s): Ron Waksman, M.D.  
6:14 PM - 6:22 PM Panel Discussion
END OF SESSION XV
 
SESSION XVI SCHEDULE
Thursday
SESSION XVI: ISVS AWARD PAPERS
x
6:23 PM - 6:31 PM The Development And Implementation Of Endovascular Capabilities In Wartime: A Report From The 332nd EMDG / Air Force Theater Hospital
  Presenters(s): Major Andrew N. Bowser, M.D.  
6:32 PM - 6:40 PM The Volume-Outcome Relationship In Abdominal Aortic Aneurysm Surgery
  Presenters(s): Peter J.E. Holt, M.R.C.S.  
6:41 PM - 6:49 PM Carotid Angioplasty And Stenting For Post Endarterectomy Stenosis: Long-Term Follow -Up
  Presenters(s): Gerrit J. de Borst, MD  
6:50 PM - 7:00 PM Panel Discussion
END OF SESSION XVI
 
SESSION XVII SCHEDULE
Friday
SESSION XVII: FOCUS ON NEW OR IMPROVED TECHNOLOGY (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D.
x
6:40 AM - 6:47 AM Design Of A Non-High Risk CAS Trial
  Presenters(s): Kenneth Ouriel, M.D., F.A.C.S., F.A.C.C.  
6:48 AM - 6:55 AM Endovascular Management Of Iliac Artery (TASC C And D) Lesions: When Should They Be Treated By PTA And Stenting And When By Open Bypass?
  Presenters(s): Sean P. Lyden, M.D.  
6:56 AM - 7:03 AM Cryo Balloon Angioplasty Broadens The Role Of Primary PTA And Reduces The Need For Stenting In Complex SFA Lesions (TASC C And D)
  Presenters(s): Karl A. Illig, M.D.  
7:04 AM - 7:11 AM Experimental Basis For Cryoplasty: Why Does It Work?
  Presenters(s): Bauer E. Sumpio, M.D., Ph.D.  
7:12 AM - 7:19 AM Open Cell Versus Closed Cell Carotid Stent Design: Indications, Advantages And Limitations Of Each
  Presenters(s): Mark H. Wholey, M.D.  
7:20 AM - 7:29 AM Panel Discussion
7:30 AM - 7:37 AM Introductory Remarks
  Presenters(s): Frank J. Veith, M.D.  
END OF SESSION XVII
 
SESSION XVIII SCHEDULE
Friday
SESSION XVIII: PROGRESS IN THE TREATMENT OF THORACIC AND THORACOABDOMINAL ANEURYSMS (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D.
x
7:38 AM - 7:45 AM Update On The US Trial With The TX2 Thoracic Endograft
  Presenters(s): Jon S. Matsumura, M.D.  
7:46 AM - 7:53 AM Ten-Year Experience With Thoracic Endografts: Lessons Learned
  Presenters(s): Ludger Sunder-Plassmann, M.D.  
7:54 AM - 8:01 AM Will We Be Able To Treat Type A Dissections With Endografts?
  Presenters(s): Edward B. Diethrich, M.D.  
8:02 AM - 8:09 AM Present And Future Role Of Endografts For The Treatment Of Dissecting Aneurysms
  Presenters(s): Michael D. Dake, M.D.  
8:10 AM - 8:17 AM Are Aortic Stent Grafts Indicated For Uncomplicated Type B Aortic Dissections: Results Of A Randomized Controlled Trial (INSTEAD Trial) Comparing Endografts To Best Medical Therapy
  Presenters(s): Christoph A. Nienaber, M.D.  
8:18 AM - 8:25 AM Top 5 Reasons Why Thoracic Endografting Is More Complex And Dangerous Than Endograft Repair Of AAAs
  Presenters(s): Frank J. Criado, M.D.  
8:26 AM - 8:33 AM Current Limitations Of Thoracic Aortic Endografts
  Presenters(s): Martin Malina, M.D., Ph.D.  
8:34 AM - 8:41 AM The Truth About Thoracic Endografts: Are They All They Are Cracked Up To Be?
  Presenters(s): Jean-Pierre Becquemin, M.D., F.R.C.S.  
8:42 AM - 8:51 AM Panel Discussion
Moderator(s): Christoph A. Nienaber, M.D. / Frank J. Veith, M.D.  
8:52 AM - 8:59 AM Evolution Of Fenestrated And Branched Endograft Devices: Will They Allow Endovascular Treatment Of All Aneurysms?
  Presenters(s): David E. Hartley, FRANZCR (Hon)  
9:00 AM - 9:07 AM Late Results With Fenestrated And Branched Endografts For Pararenal And Thoracoabdominal Aneurysms
  Presenters(s): John L. Anderson, M.D.  
9:08 AM - 9:15 AM Lessons Learned From A 5-Year Experience With Fenestrated Endografts
  Presenters(s): Michael Lawrence-Brown, M.B,B.S., F.R.A.C.S.  
9:16 AM - 9:23 AM New Hybrid Technique (Endo/Open) For Complex Aneurysms Requiring Branched Grafts
  Presenters(s): Mario Lachat, M.D.  
9:24 AM - 9:31 AM Open Surgical Repair Of Descending Thoracic Aneurysms In The Endovascular Era: A 10-Year Experience
  Presenters(s): Edouard Kieffer, M.D.  
9:32 AM - 9:39 AM What Patients Will Never Be Suitable For Aortic Endograft Treatment?
  Presenters(s): Hazim J. Safi, M.D.  
9:40 AM - 9:49 AM Panel Discussion
END OF SESSION XVIII
 
SESSION XIX SCHEDULE
Friday
SESSION XIX: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ARTERIAL DISEASE BY OPEN SURGERY (5-MINUTE TALKS WITH 2 QUESTIONS AFTER EACH TALK - NO PANEL)
Moderators:Mark A. Adelman, M.D.
x
9:50 AM - 9:55 AM Lower Extremity Bypass Grafting Improves Quality Of Life: Results Of An 83-Center Study From The PREVENT Trial
  Presenters(s): Gregory L. Moneta, M.D.  
9:56 AM - 10:01 AM Duplex Guided Suction Thromboembolectomy – Techniques And Results: Is It A Better Way?
  Presenters(s): Enrico Ascher, M.D.  
10:02 AM - 10:07 AM Debate: Minimally Invasive Vein Harvest Is Better For Lower Extremity Bypasses
  Presenters(s): Peter Gloviczki, M.D.  
10:08 AM - 10:13 AM Debate: Compromised Bypass Outcomes After Minimal Incision Vein Harvest: It May Not Be A Better Way
  Presenters(s): Thomas E. Brothers, M.D.  
10:14 AM - 10:19 AM Is There A Role For Endografts In The Treatment Of Long Segment SFA Occlusion?
  Presenters(s): Thomas F. Panetta, M.D.  
10:20 AM - 10:25 AM Femoropopliteal Bypass Is Still The Gold Standard For SFA Disease
  Presenters(s): John E. Connolly, M.D.  
10:26 AM - 10:31 AM Debate: Have Distal Anastomotic Vein Patches/Cuffs Or Distally Hooded Grafts Proven To Be Better Than Standard Prosthetic Grafts To Infrapopliteal Arteries?
  Presenters(s): Paul J. Gagne, M.D.  
10:32 AM - 10:37 AM Debate: All This Stuff About Patches, Cuffs And Hoods Is Nonsense
  Presenters(s): Evan C. Lipsitz, M.D.  
10:38 AM - 10:43 AM Improved 3-Year Patency Of Heparin Bonded PTFE (Propaten™) Grafts For Leg Bypasses
  Presenters(s): Patrick Peeters, M.D.  
10:44 AM - 10:49 AM What Factors Affect Lower Extremity Graft Failure? Can Any Be Modified?
  Presenters(s): Anton N. Sidawy, M.D., M.P.H.  
10:50 AM - 10:55 AM Management Of Popliteal Artery Injuries In The War On Terrorism: Can Limbs Be Saved And How?
  Presenters(s): David L. Gillespie, M.D.  
10:56 AM - 11:01 AM A New Swirl Design For Prosthetic Bypass Grafts: Reasons Why This May Be Better Than Existing Grafts: Experimental And Early Clinical Results
  Presenters(s): Nicholas J.W. Cheshire, M.D.  
END OF SESSION XIX
 
SESSION XX SCHEDULE
Friday
SESSION XX: ADVANCES IN MEDICAL TREATMENTS OR TREATMENTS OF MEDICAL PROBLEMS IN VASCULAR PATIENTS (7-MINUTE TALKS)
Moderators:William H. Pearce, M.D.
x
11:02 AM - 11:09 AM Apo A-1 Milano Analogues, Torceptrapib, D-4F And Other HDL Raising Drugs: How Do They Work?
  Presenters(s): Russell H. Samson, M.D., F.A.C.S., R.V.T.  
11:10 AM - 11:17 AM Will Apo A-1 Milano Analogues And Other Medications Promote Clearing Of Atherosclerotic Plaque? When Will They Be Available?
  Presenters(s): Stephen Nicholls, M.D.  
11:18 AM - 11:25 AM Implantable Carotid Sinus Electrical Stimulation With The Rheos System For Treatment Of Drug Resistant Hypertension: Early Clinical Demonstration Of Safety And Effectiveness From A Multicenter Trial
  Presenters(s): Jürg Schmidli, M.D.  
11:26 AM - 11:33 AM Adjunctive Medical Therapies In Lower Extremity Bypass Surgery
  Presenters(s): Michael S. Conte, M.D.  
11:34 AM - 11:41 AM Hemodynamic Changes During CAS: Their Prevention Prevents Stroke And Mandates An Anesthesiologist For The Procedure
  Presenters(s): Marc R.H. van Sambeek, M.D., Ph.D.  
11:42 AM - 11:49 AM Preoperative Studies And Appropriate Coronary Revascularization Are Not Worthwhile In Vascular Surgery Patients With And Without Coronary Artery Disease: Based On A Large Multicenter Randomized Trial
  Presenters(s): Joseph H. Rapp, M.D.  
11:50 AM - 11:57 AM Myths And Facts Regarding The Expanding Global Epidemic Of Cardiovascular Disease: What Can Be Done To Stop It?
  Presenters(s): Allan D. Callow, M.D., Ph.D.  
11:58 AM - 12:05 PM Panel Discussion
12:05 PM - 1:00 PM Lunch Break
END OF SESSION XX
 
SESSION XXI SCHEDULE
Friday
SESSION XXI: MORE ABOUT ANEURYSMS AND THEIR TREATMENT (7-MINUTE TALKS)
Moderators:Geoffrey H. White, M.D.
x
1:00 PM - 1:07 PM Accepted Indications For Thoracic Endografts In France: Are These Reasonable In View Of Current Knowledge Worldwide?
  Presenters(s): Patrice F. Bergeron, M.D.  
1:08 PM - 1:15 PM Thoracic Aortic Dissections: Choosing The Right Techniques For Evaluation And Treatment
  Presenters(s): David M. Williams, M.D.  
1:16 PM - 1:23 PM How To Deal With Mobile Plaque In The Thoracic Aorta: Diagnosis, Prognosis And Treatment
  Presenters(s): Lars G. Svensson, M.D., Ph.D  
1:24 PM - 1:31 PM Experience With A New Device (Proximal Covered Stent/Distal Open Stent) For Treatment Of Type B Aortic Dissections
  Presenters(s): Joseph V. Lombardi, M.D.  
1:32 PM - 1:39 PM Technical Tips For Stent-Graft Treatment Of Aortic Dissections: Important Precautions And Optimal Imaging
  Presenters(s): Burkhart Zipfel, M.D.  
1:40 PM - 1:47 PM Device Problems In The Curvature Zone Of The Upper Thoracic Aorta: How Can They Be Prevented?
  Presenters(s): Geoffrey H. White, M.D.  
1:48 PM - 1:55 PM What Is Happening With EVAR In Belgium? On What Basis Is There Difficulty With Reimbursement For EVAR? What Were The Findings And Flaws In The Belgian EUROSTAR Data?
  Presenters(s): Patrick Peeters, M.D.  
1:56 PM - 2:03 PM Percutaneous AAA Repair: Technical Improvements, Precautions And Contraindications: Is It For Every Surgeon? For Every Patient?
  Presenters(s): Zvonimir Krajcer, M.D., F.A.C.C.  
2:04 PM - 2:13 PM Panel Discussion
END OF SESSION XXI
 
SESSION XXII SCHEDULE
Friday
SESSION XXII: PROGRESS IN VASCULAR IMAGING (7-MINUTE TALKS)
Moderators:Frans L. Moll, M.D., Ph.D. / Jacques Busquet, M.D.
x
2:14 PM - 2:21 PM Can CT Coronary Arteriography Now Replace Catheter Contrast Arteriography? If We Can Image The Coronaries We Can Image Anything
  Presenters(s): Geoffrey D. Rubin, M.D.  
2:22 PM - 2:29 PM Dynamic Cine MRA And CT To Evaluate AAA Morphology Before And After EVAR: Will It Obviate The Need For Sac Pressure Measurements And Importance With Branched Grafts To The Renal Arteries?
  Presenters(s): Hence J.M. Verhagen, M.D., Ph.D.  
2:30 PM - 2:37 PM Technique Of Virtual Histology Intravascular Ultrasound: Its Role In Assessing Plaque Morphology And Influencing Patient Selection And Management With Carotid Lesions
  Presenters(s): Donald B. Reid, M.D.  
2:38 PM - 2:45 PM Carotid Plaque Analysis By Ultrasound Activity Index: What Role Should It Play In Determining Which Patients Need Intervention And What That Intervention Should Be?
  Presenters(s): Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS  
2:46 PM - 2:53 PM Does Duplex Carotid Evaluation Lead To Over-Utilization Of Prophylactic Carotid Interventions?
  Presenters(s): Gregory L. Moneta, M.D.  
2:54 PM - 3:01 PM How To Credential Vascular Surgeons Adequately For Reading Vascular Lab Studies
  Presenters(s): R. Eugene Zierler, M.D.  
3:02 PM - 3:10 PM Panel Discussion
END OF SESSION XXII
 
SESSION XXIII SCHEDULE
Friday
SESSION XXIII: INTERESTING NEW DEVELOPMENTS IN DIALYSIS ACCESS AND VASCULAR TREATMENTS (7-MINUTE TALKS)
Moderators:Larry A. Scher, M.D. / Thomas M. Vesely, M.D.
x
3:11 PM - 3:18 PM Should All ESRD Patients Have An AV Fistula: A Retrospective Review Of 1,700 Consecutive Patients
  Presenters(s): A. Frederick Schild, M.D.  
3:19 PM - 3:26 PM The Use Of The U-Clip In Hemodialysis Access Surgery
  Presenters(s): Marc H. Glickman, M.D.  
3:27 PM - 3:34 PM How To Best Revise Failing Venous Bypass Grafts: Which Is Better, Venous Patches Or Interposition Grafts?
  Presenters(s): R. Clement Darling III, M.D.  
3:35 PM - 3:42 PM New Technology For Direct Intravascular Delivery Of Nitric Oxide As A Therapeutic Agent: Experimental And Early Pre-Clinical Experience
  Presenters(s): Barry T. Katzen, M.D.  
3:43 PM - 3:49 PM Panel Discussion
END OF SESSION XXIII
 
SESSION XXIV SCHEDULE
Friday
SESSION XXIV: NEW DEVELOPMENTS IN VENOUS DISEASE AND ITS TREATMENT (6-MINUTE TALKS)
Moderators:J. Leonel Villavicencio, M.D. / Norman M. Rich, M.D., F.A.C.S, D.M.C.C.
x
3:50 PM - 3:56 PM The Future Of Venous Disease And Its Treatment
  Presenters(s): Bo G. Eklof, M.D., Ph.D.  
3:57 PM - 4:03 PM Present Role Of IVC Filter Placement In Patients Undergoing Open And Laparoscopic Gastric Bypass: Techniques, Indications And Effectiveness
  Presenters(s): Nicholas J. Gargiulo III, M.D.  
4:04 PM - 4:10 PM Temporary IVC Filters: Lessons Learned After 100 Retrievals: What Is The Future?
  Presenters(s): David Rosenthal, M.D.  
4:11 PM - 4:17 PM DVT – When To Treat, When Not To Treat: Use Of Lysis And Mechanical Thrombectomy
  Presenters(s): Cynthia K. Shortell, M.D.  
4:18 PM - 4:24 PM Role Of New Biomarkers In The Diagnosis And Management Of DVT: Do They Really Help?
  Presenters(s): Thomas W. Wakefield, M.D.  
4:25 PM - 4:31 PM Update On Endovenous Valve Replacement: Long-Term Results
  Presenters(s): Dusan Pavcnik, M.D., Ph.D.  
4:32 PM - 4:38 PM Dangerous Venous Crossings By Arteries: Location, Pathology And Optimal Treatment
  Presenters(s): J. Leonel Villavicencio, M.D.  
4:39 PM - 4:45 PM PTA Without Stenting Is Effective For Central Brachiocephalic Vein Stenoses: When Are Stents Indicated?
  Presenters(s): Samuel S. Ahn, M.D.  
4:46 PM - 4:55 PM Panel Discussion
Moderator(s): Bo G. Eklof, M.D., Ph.D. / Thomas F. O'Donnell, Jr., M.D.  
4:56 PM - 5:02 PM Treatment Of Venous Ulcers By Excision And Split Thickness
  Presenters(s): Kevin G. Burnand, M.B.B.S., F.R.C.S., M.S.  
5:03 PM - 5:09 PM Saphenous Nerve Injury With Vein Surgery: Incidence, Diagnosis, Impact, Prevention And Treatment
  Presenters(s): Michael C. Dalsing, M.D.  
5:10 PM - 5:16 PM Trials, Tribulations And Advantages Of Opening A Freestanding Outpatient Vein Center
  Presenters(s): Richard A. Baum, M.D.  
5:17 PM - 5:23 PM Evolving View Of The Importance Of The Small (Lesser) Saphenous Vein In The Management Of Venous Disease: Is It An Often Neglected Component?
  Presenters(s): Thomas F. O'Donnell, Jr., M.D.  
5:24 PM - 5:30 PM Technique And Results Of Ultrasound Guided Sclerotherapy For Perforator Veins: A Better Simpler Way Than SEPS
  Presenters(s): Elna M. Masuda, M.D.  
5:31 PM - 5:37 PM Incidence And Significance Of Upper Torso DVT: Does It Lead To Pulmonary Emboli And Is Anticoagulation Indicated?
  Presenters(s): Fred A. Weaver, M.D.  
5:38 PM - 5:44 PM Debate: Foam Sclerotherapy Will Eliminate Open And Endovascular Therapy For Varicose Veins
  Presenters(s): John J. Bergan, M.D.  
5:45 PM - 5:51 PM Debate: Foam Sclerotherapy Will Not Eliminate Other Treatments For Varicose Veins: What Are Its Uses?
  Presenters(s): Jose I. Almeida, M.D., F.A.C.S., R.V.T.  
5:52 PM - 6:00 PM Panel Discussion
6:00 PM - 7:00 PM ISVS Business Meeting
END OF SESSION XXIV
 
SESSION XXV SCHEDULE
Saturday
SESSION XXV: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM REPAIR: OPEN, EVAR AND OTHER LESS INVASIVE TECHNIQUES (7-MINUTE TALKS)
Moderators:Malcolm O. Perry, M.D. / Daniel G. Clair, M.D.
x
6:40 AM - 6:47 AM What Is The Real Current Durability Of Conventional Open AAA Repair? Is It Really Better Than That Of EVAR?
  Presenters(s): Richard P. Cambria, M.D.  
6:48 AM - 6:55 AM Open Surgery For AAA With New Techniques: Is This A Hibernating Or An Extinct Procedure?
  Presenters(s): Jeffrey L. Ballard, M.D., F.A.C.S.  
6:56 AM - 7:03 AM New Developments In Laparoscopic AAA Surgery: What Can It Do That EVAR Cannot And Vice Versa?
  Presenters(s): Olivier A. Goëau-Brissonnière, M.D., Ph.D.  
7:04 AM - 7:11 AM New Instrumentation And Approaches To Make Laparoscopic Aortic Surgery Easier
  Presenters(s): Yves S. Alimi, M.D.  
7:12 AM - 7:19 AM A New Stapling Device To Simplify Laparoscopic And Open Aortic Surgery: Why Is It Better Than Others?
  Presenters(s): Ralf R. Kolvenbach, M.D.  
7:20 AM - 7:27 AM Steerable Arms With Multiple Degrees Of Freedom Of Motion To Facilitate Laparoscopic Aortic Surgery: Do We Really Need A Costly Robot?
  Presenters(s): Willem Wisselink, M.D.  
7:28 AM - 7:35 AM Long-Term (5-Year) Results With AAA Endografts: Are There Differences In Grafts And Results?
  Presenters(s): Jon S. Matsumura, M.D.  
7:36 AM - 7:45 AM Panel Discussion
Moderator(s): Enrico Ascher, M.D. / Gregorio A. Sicard, M.D.  
7:46 AM - 7:53 AM All Studies Relating Natural History And Behavior Of AAAs To CT Size Are Unreliable And Flawed Because Standard CT Measurements Are Inaccurate
  Presenters(s): George H. Meier III, M.D.  
7:54 AM - 8:01 AM In EVAR II Clinicians Scored The Patients Unfit For Open Repair And EVAR Did No Better Than Best Medical Management: However, EVAR Beats Open Repair In "High Risk" Patients
  Presenters(s): Roger M. Greenhalgh, M.D.  
8:02 AM - 8:09 AM EVAR II May Be Level I Evidence But It May Be Misleading And Should Not Keep Us From Performing EVAR On High Risk Patients
  Presenters(s): Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E.  
8:10 AM - 8:17 AM EVAR On High Risk Patients Is Worthwhile In The US: Nationwide Procedural Mortality Statistics Show The Conclusions Of EVAR II Do Not Apply In The USA
  Presenters(s): Carlos H. Timaran, M.D.  
8:18 AM - 8:25 AM Is Fenestrated EVAR Appropriate For High Risk Patients? Might EVAR II Be Misleading For Canadian Patients?
  Presenters(s): Randy D. Moore, M.D.  
8:26 AM - 8:33 AM Limited Open Exposure Techniques To Treat Persistent Type I And II Endoleaks: How To Do Them
  Presenters(s): Martin R. Back, M.D.  
8:34 AM - 8:41 AM Four-Year Results With The Gore TAG Endograft For TAAs
  Presenters(s): Michel S. Makaroun, M.D.  
8:42 AM - 8:52 AM Panel Discussion
END OF SESSION XXV
 
SESSION XXVI SCHEDULE
Saturday
SESSION XXVI: NEW DEVELOPMENTS IN THE TREATMENT OF DISEASES OF THE AORTA AND ITS MAJOR ABDOMINAL BRANCHES (7-MINUTE TALKS)
Moderators:Hugh G. Beebe, M.D.
x
8:53 AM - 9:00 AM Is EVAR And Bilateral Hypogastric Artery Interruption – When Necessary – Really So Dangerous?
  Presenters(s): Armando C. Lobato, M.D., PhD.  
9:01 AM - 9:08 AM Branched Grafts For Hypogastric Revascularization: Indications And Contraindications
  Presenters(s): Eric L.G. Verhoeven, M.D., Ph.D.  
9:09 AM - 9:16 AM Outcomes After Hypogastric Artery Bypass And Embolization With EVAR
  Presenters(s): W. Anthony Lee, M.D.  
9:17 AM - 9:24 AM Endovascular Treatment Of Visceral Artery Aneurysms: When Is It Feasible, When Not?
  Presenters(s): Daniel G. Clair, M.D.  
9:25 AM - 9:32 AM Current Endoluminal And Open Treatment Of Peripancreatic (Gastroduodenal, Pancreatico-duodenal And Splenic) Artery Aneurysms
  Presenters(s): James C. Stanley, M.D.  
9:33 AM - 9:40 AM Retrograde Open Mesenteric Stenting: Advantages In Patients With Acute Mesenteric Ischemia Superimposed On Chronic – And With Dead Bowel
  Presenters(s): Richard J. Powell, M.D.  
9:41 AM - 9:48 AM Atherosclerotic Renovascular Disease Is More Benign Than We Thought: Data From A Prospective Population Based Study
  Presenters(s): Kimberley J. Hansen, M.D.  
9:49 AM - 9:59 AM Panel Discussion
END OF SESSION XXVI
 
SESSION XXVII SCHEDULE
Saturday
SESSION XXVII: ISSUES AND UPDATES ON THE ISVS, THE ABVS, THE SVS AND THE PRIMARY CERTIFICATE: PROS AND CONS AND WHERE IS VASCULAR SURGERY GOING (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D. / Blair A. Keagy, M.D.
x
10:00 AM - 10:07 AM What Is Happening With The ISVS? Progress Made And Relationship With This Meeting And Other Organizations: Why All Vascular Surgeons And Others Should Join
  Presenters(s): Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E.  
10:08 AM - 10:15 AM How To Meet Current Challenges To Surgical Education In Today’s Unfriendly Environment
  Presenters(s): Thomas S. Riles, M.D.  
10:16 AM - 10:23 AM Current And Future Roles Of Various SVS Publications And Outlets: The Vascular Web, Vascular Specialist And The JVS – What They Mean For Vascular Surgeons
  Presenters(s): K. Wayne Johnston, M.D., F.R.C.S.  
10:24 AM - 10:31 AM What The SVS Is Doing To Define, Protect And Support Vascular Surgery In A Changing World
  Presenters(s): Enrico Ascher, M.D.  
10:32 AM - 10:39 AM What New Pathways Are Available To Train Vascular Surgeons Under The Primary Certificate? Are They Working And How Many Programs Have Applied?
  Presenters(s): Jerry Goldstone, M.D., F.A.C.S., F.R.C.S., Ed  
10:40 AM - 10:47 AM Why The Primary Certificate In Vascular Surgery Will Fail To Meet The Needs Of The Specialty
  Presenters(s): Ramon Berguer, M.D., Ph.D.  
10:48 AM - 10:55 AM Status Of The ABVS: Where Do We Go From Here To Gain Independent Board Status?
  Presenters(s): Robert W. Hobson II, M.D.  
10:56 AM - 11:05 AM Panel Discussion
END OF SESSION XXVII
 
SESSION XXVIII SCHEDULE
Saturday
SESSION XXVIII: LEGAL, BUSINESS AND OTHER ISSUES FOR VASCULAR SURGEONS AND INTERVENTIONALISTS (7-MINUTE TALKS)
Moderators:Richard M. Green, M.D.
x
11:06 AM - 11:13 AM Medical Malpractice And The Vascular Surgeon: What Can Be Done To Help Us?
  Presenters(s): O. William Brown, M.D., J.D.  
11:14 AM - 11:21 AM Legal Methods And Strategies To Overcome The Managed Care Monster: How To Level The Playing Field
  Presenters(s): David A. Manko, J.D.  
11:22 AM - 11:29 AM How To Optimize Vascular Surgery Billing
  Presenters(s): Sean P. Roddy, M.D.  
11:30 AM - 11:37 AM Present Status Of Vascular Surgery Reimbursement And Prospects For The Future
  Presenters(s): Robert M. Zwolak, M.D., Ph.D.  
11:38 AM - 11:45 AM A Close-Up View Of Combat Surgery In Iraq: We Owe Our Armed Forces An Enormous Debt Of Gratitude
  Presenters(s): Stephen F. McCartney, M.D., F.A.C.S.  
11:46 AM - 12:00 PM Panel Discussion
END OF SESSION XXVIII
 
SESSION XXX SCHEDULE
Saturday
SESSION XXX: PHILOSOPHICAL, ETHICAL AND JUDGMENT ISSUES FOR VASCULAR SURGEONS AND INTERVENTIONALISTS (7-MINUTE TALKS)
Moderators:Julius H. Jacobson II, M.D. / Robert B. Rutherford, M.D.
x
1:05 PM - 1:12 PM Ethical Issues Surrounding Live Case Demonstrations: Who Benefits And Who Pays A Price?
  Presenters(s): Dorothy B. Abel, B.S.B.M.E.  
1:13 PM - 1:20 PM Judgment Issues In Endovascular Procedures: What Motivates Us And What Should Motivate Us?
  Presenters(s): Lindsay S. Machan, M.D.  
1:21 PM - 1:28 PM Prospective Decision Analysis Computer Modeling Indicates Clinical Decisions In Vascular Surgery Often Fail To Maximize Patient Benefit
  Presenters(s): Thomas E. Brothers, M.D.  
1:29 PM - 1:36 PM How To Resolve Ethics Issues In Physician-Industry Relationships
  Presenters(s): Timothy M. Sullivan, M.D.  
1:37 PM - 1:43 PM Panel Discussion
END OF SESSION XXX
 
SESSION XXXI SCHEDULE
Saturday
SESSION XXXI: NEW DEVELOPMENTS IN PREVENTION AND TREATMENT OF COMPLICATIONS (6-MINUTE TALKS)
Moderators:Wesley S. Moore, M.D.
x
1:44 PM - 1:50 PM Statin Treatment And EVAR: Do Statins Reduce The Risk Of Cardiovascular Complications?
  Presenters(s): Jacob Buth, M.D.  
1:51 PM - 1:57 PM Are Prophylactic Antibiotic Regimens For Vascular Surgery Out Of Date In The MRSA Era? What Should Our Current Prophylaxis Be?
  Presenters(s): Samuel Eric Wilson, M.D.  
1:58 PM - 2:04 PM A New Endovascular Approach For Treating Serous Collections Associated With Prosthetic Arterial Grafts
  Presenters(s): Nicholas J. Gargiulo III, M.D.  
2:05 PM - 2:11 PM VAC-On-Vessel: A New Better Way To Treat Vascular Graft Infections: Why Does It Work So Well?
  Presenters(s): Dieter O. Mayer, M.D.  
2:12 PM - 2:18 PM New Uses For Deep Vein Grafts: Radical Treatment Of Infected Femoral Pseudoaneurysms, For Femoro-Femoral Bypass, And For Ileorenal And Ileovisceral Artery Bypass With Complex AAAs Treated By EVAR
  Presenters(s): G. Patrick Clagett, M.D.  
2:19 PM - 2:25 PM Metallic Silver Impregnated Grafts For Use To Treat Infected Prosthetic Grafts By In Situ Replacement In The Infected Field
  Presenters(s): Max Zegelman, M.D., Ph.D.  
2:26 PM - 2:32 PM Ten-Year Perspective On Procedural And Postprocedural Complications Of Aortic Endografting: Which Complications Remain A Challenge?
  Presenters(s): Mohan Adiseshiah, F.R.C.S.  
2:33 PM - 2:39 PM Can Visual Inspection Of A CT Scan Predict AAA Rupture Risk? Where Does Finite Element Analysis Fit In And What Measurable AAA Characteristics Produce High Areas Of Wall Stress?
  Presenters(s): David A. Vorp, Ph.D.  
2:40 PM - 2:49 PM Panel Discussion
END OF SESSION XXXI
 
SESSION XXXII SCHEDULE
Saturday
SESSION XXXII: NEW TECHNIQUES AND CONCEPTS WHICH WILL SHAPE OUR FUTURE (6-MINUTE TALKS)
Moderators:Michael B. Silva, Jr., M.D.
x
2:50 PM - 2:56 PM How Vascular Surgeons Should Obtain Exposure For Spine Surgery: Tips, Precautions And Hints For Optimizing Billing
  Presenters(s): Mark D. Morasch, M.D.  
2:57 PM - 3:03 PM Recent Advances And Potential In Nanotechnology And Biotechnology
  Presenters(s): Elliot L. Chaikof, M.D., Ph.D.  
3:04 PM - 3:10 PM How Are Simulators Valuable In Teaching Endovascular Techniques? Is There Proof Of Effectiveness?
  Presenters(s): K. Craig Kent, M.D.  
3:12 PM - 3:18 PM Cook Zenith Flex Endograft: Improved Technological Features With Main Body Diameters Up To 36 mm
  Presenters(s): Luis A. Sanchez, M.D.  
3:18 PM - 3:24 PM Pharmacological Treatment Of Aneurysms: The Next Horizon
  Presenters(s): Juan C. Parodi, M.D.  
3:25 PM - 3:31 PM Should AAAs <5.0 - 5.5 cm Be Treated? Do We Know? How Can We Find Out?
  Presenters(s): Kenneth Ouriel, M.D., F.A.C.S., F.A.C.C.  
3:32 PM - 3:38 PM EVAR 5-Year Results With Small vs. Large AAAs: Is Big Really Worse?
  Presenters(s): Jeffrey P. Carpenter, M.D.  
3:39 PM - 3:49 PM Panel Discussion
Moderator(s): K. Craig Kent, M.D. / Joseph L. Mills, M.D.  
3:49 PM - 3:55 PM Beyond Fusiform And Saccular: Three Dimensional Aortic Shape And Rupture Potential: Does It Correlate With Finite Element Analysis?
  Presenters(s): Alan Dardik, M.D., Ph.D.  
3:56 PM - 4:02 PM Laparoscopic Guided Endovascular Access To The Aorta And Iliac Vessels
  Presenters(s): Michael Lawrence-Brown, M.B,B.S., F.R.A.C.S.  
4:03 PM - 4:09 PM Initial Experience With The VI - Aortounilateral Endograft For AAA
  Presenters(s): Ralf R. Kolvenbach, M.D.  
4:10 PM - 4:16 PM Phase I US Fenestrated Endograft Trial: The Procedure Can Work In The Real World
  Presenters(s): Christopher J. Kwolek, M.D.  
4:17 PM - 4:23 PM Techniques And Experience With In Situ Fenestration And Branched Grafts
  Presenters(s): Richard G. McWilliams, M.D.  
4:24 PM - 4:30 PM Supra-Aortic Revascularization After Thoracic Aneurysm Stent-Grafting By In Situ Fenestration And Endografting Via The Innominate And Carotid Arteries
  Presenters(s): Ramesh K. Tripathi, M.D., F.R.C.S., F.R.A.C.S.  
4:31 PM - 4:37 PM Instant In Situ Fenestration To Allow Endo Treatment Of Urgent AAAs With Short Necks: Technique And Limitations
  Presenters(s): Martin Malina, M.D., Ph.D.  
4:38 PM - 4:44 PM Do We Need A New Endograft To Treat Traumatic Aortic Disruption And Why?
  Presenters(s): Alan B. Lumsden, M.D., F.A.C.S.  
4:45 PM - 4:55 PM Panel Discussion
Moderator(s): James A. DeWeese, M.D. / Donna M. Mendes, M.D., F.A.C.S.  
4:56 PM - 5:02 PM Absorbable Polylactic Acid Stents: Clinical Experience, Value And Limitations
  Presenters(s): Giancarlo Biamino, M.D.  
5:03 PM - 5:09 PM Can Aortobronchial Fistulas Be Treated Successfully By Open Surgery? By Endovascular Means?
  Presenters(s): Michael J. Jacobs, M.D.  
5:10 PM - 5:16 PM Progress In Myocyte And Stem Cell Transplantation For Inadequate Myocardial Function
  Presenters(s): Edward B. Diethrich, M.D.  
5:17 PM - 5:23 PM Bone Marrow Stem Cell Injections: Can They Be A Treatment For Critical Ischemia And How Do They Work?
  Presenters(s): Berthold Amann, M.D.  
5:24 PM - 5:30 PM Does Red Wine Have A Cardiovascular Protective Effect? How Does It Work?
  Presenters(s): Bauer E. Sumpio, M.D., Ph.D.  
5:31 PM - 5:37 PM EVAR Reduces The Risk Of Rupture Despite Persisting Type I Endoleak: How Can This Possibly Be True?
  Presenters(s): Christopher K. Zarins, M.D.  
5:38 PM - 5:44 PM The Importance Of Fish Oils: Why All Vascular Patients Should Be On Them, How Do They Work And What Is The Dosage?
  Presenters(s): William M. Stone, M.D.  
5:45 PM - 5:51 PM The LeMaitre-Endofit Thoracic Endograft: Clinical Trial Update
  Presenters(s): Dieter Raithel, M.D., Ph.D.  
5:52 PM - 5:58 PM Late Breaking Developments: Interesting New Findings From The SVS Carotid Registry - A Real Step Forward
  Presenters(s): Anton N. Sidawy, M.D., M.P.H.  
5:59 PM - 6:10 PM Panel Discussion
END OF SESSION XXXII
 
SESSION XXIX SCHEDULE
Saturday
SESSION XXIX: SPECIAL LUNCHEON SESSION ON IMPROVED NEW ENDOGRAFT TECHNOLOGIES (6-MINUTE TALKS WITH LUNCH PROVIDED)
Moderators:Juan C. Parodi, M.D. / James May, M.D., M.S., F.R.A.C.S., F.A.C.S.
x
12:00 PM - 12:06 PM Features Of An Improved Medtronic Thoracic Endograft: The Valiant Stent-Graft
  Presenters(s): Ronald M. Fairman, M.D.  
12:07 PM - 12:13 PM Aortic Arch Replacement: What Is The Next Generation Thoracic Endograft Going To Look Like?
  Presenters(s): Roy K. Greenberg, M.D.  
12:14 PM - 12:20 PM Features Of And Early Results With The Endurant Endograft For EVAR: The Next Generation AAA Stent-Graft From Medtronic
  Presenters(s): Hence J.M. Verhagen, M.D., Ph.D.  
12:21 PM - 12:27 PM Aorfix™ Endograft: A New More Flexible Stent-Graft For EVAR: Early Clinical Results With Sharply Angulated Neck And Iliac Anatomy
  Presenters(s): Brian R. Hopkinson, Ch.M., F.R.C.S.  
12:28 PM - 12:34 PM Remodeling Of AAA Morphology 5 Years After EVAR With The Endologix Endograft
  Presenters(s): Rodney A. White, M.D.  
12:35 PM - 12:41 PM Laparoscopy And EVAR: There Is A Place For Both
  Presenters(s): Yves-Marie Dion, M.D., M.Sc.  
12:42 PM - 12:48 PM Clinical Trial Results With The Endologix Aortouni-iliac Endograft
  Presenters(s): Rodney A. White, M.D.  
12:49 PM - 12:56 PM Anatomical Characteristics That Make A Patient Suitable For Carotid Stenting And What Percentage Of Patients Fall In This Category: Delphi Consensus
  Presenters(s): Sumaira Macdonald, MBChB (Comm), MRCP, FRCR, PhD  
12:57 PM - 1:04 PM Panel Discussion
END OF SESSION XXIX
 
SESSION XXXIII SCHEDULE
Sunday
SESSION XXXIII: RECENT ADVANCES AND UPDATES (7-MINUTE TALKS)
Moderators:Thomas S. Riles, M.D. / Dhiraj M. Shah, M.D.
x
6:40 AM - 6:47 AM Vascular Challenges After Blunt Trauma To The Thoracic Aorta: Principles In Management And Optimal Techniques For Repair
  Presenters(s): Kenneth L. Mattox, M.D.  
6:48 AM - 6:55 AM Contemporary Management Of A-V Malformations With A Multidisciplinary Approach
  Presenters(s): Byung-Boong Lee, M.D.  
6:56 AM - 7:03 AM Why Renal Arteries Get Covered During EVAR: How To Avoid This Mishap
  Presenters(s): James May, M.D., M.S., F.R.A.C.S., F.A.C.S.  
7:04 AM - 7:11 AM Update On The CardioMems Implantable Pressure Sensor For EVAR: Advantages And Limitations
  Presenters(s): Ross Milner, M.D.  
7:12 AM - 7:19 AM Direct Intrasac Pressure Measurements Of Selected Patients After EVAR Suggest Long-Term Intrasac Pressure Telemetry May Not Replace Conventional Surveillance Imaging Techniques
  Presenters(s): Martin Malina, M.D., Ph.D.  
7:20 AM - 7:27 AM Tissue Engineered Vascular Grafts: Will They Ever Work?
  Presenters(s): Bo Risberg, M.D., Ph.D.  
7:28 AM - 7:37 AM Panel Discussion
Moderator(s): James F. McKinsey, M.D. / Robert B. Rutherford, M.D.  
7:38 AM - 7:45 AM Treatment Strategies For Type II Endoleaks: How My Thoughts Have Changed
  Presenters(s): Richard A. Baum, M.D.  
7:46 AM - 7:53 AM What I Have Learned About Type II Endoleaks: How Benign They Are; And How To Detect Them
  Presenters(s): Kim J. Hodgson, M.D.  
7:54 AM - 8:01 AM The Fate Of Endoleaks Detected By CT But Not Detected By Color Flow Duplex Ultrasonography After EVAR: Can They Be Ignored?
  Presenters(s): Ali F. AbuRahma, M.D.  
8:02 AM - 8:09 AM Type II Endoleaks Are Not So Benign After All: They Can Produce AAA Rupture Without An Associated Type I Endoleak
  Presenters(s): David C. Brewster, M.D.  
8:10 AM - 8:17 AM Endovascularly Placed CANCION Device For The Treatment Of Refractory Congestive Heart Failure
  Presenters(s): Steven F. Bolling, M.D.  
8:18 AM - 8:24 AM Panel Discussion
END OF SESSION XXXIII
 
SESSION XXXIV SCHEDULE
Sunday
SESSION XXXIV: MORE NEW INFORMATION ON ANEURYSMS AND THORACIC AORTIC DISEASE (7-MINUTE TALKS)
Moderators:Daniel G. Clair, M.D.
x
8:25 AM - 8:30 AM DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - Against The Motion
  Presenters(s): William P. Paaske, M.D., DrMedSci, FRCS, FRCS Ed, FACS  
8:31 AM - 8:36 AM DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - Against The Motion
  Presenters(s): Marc R.H. van Sambeek, M.D., Ph.D.  
8:37 AM - 8:45 AM DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - For The Motion
  Presenters(s): Christos D. Liapis, M.D.  
8:46 AM - 8:53 AM The Relay Thoracic Endograft: Technique And Early Results With A New Kind Of Stent-Graft Which Facilitates Easy Precise Placement In A Tortuous Proximal Aortic Arch
  Presenters(s): Vicente Riambau, M.D., Ph.D.  
8:54 AM - 9:01 AM EUROSTAR Real World Experience With Thoracic Endografts: Is It A Cause For Optimism Or A Cause For Concern?
  Presenters(s): Peter L. Harris, M.D., F.R.C.S.  
9:02 AM - 9:09 AM Two- And Three-Dimensional Criteria For Estimating AAA Rupture Risk
  Presenters(s): Mark F. Fillinger, M.D.  
9:10 AM - 9:17 AM The Need To Include "Best Medical Care In Trials Evaluating Carotid Angioplasty And Stenting"
  Presenters(s): Anthony J. Comerota, M.D., F.A.C.S.  
9:18 AM - 9:25 AM The VALOR Trial Of Talent Endografts For A Variety Of Thoracic Aortic Lesions In High Risk Patients: The Real World Experience
  Presenters(s): Mark A. Farber, M.D.  
9:26 AM - 9:33 AM Debate: IVUS Is The Best Adjunctive Method For Performing Thoracic Endografting: What Are Its Limitations?
  Presenters(s): Rodney A. White, M.D.  
9:34 AM - 9:41 AM Debate: Transesophageal Echo Is The Best Adjunctive Method For Performing Thoracic Endografting: What Are Its Limitations?
  Presenters(s): Dietmar H. Koschyk, M.D.  
9:42 AM - 9:49 AM Low Permeability Modifications Of The Gore Excluder And TAG Grafts Affect AAA And TAA Sac Behavior In A Beneficial Way
  Presenters(s): Thomas C. Naslund, M.D.  
9:50 AM - 10:00 AM Panel Discussion
END OF SESSION XXXIV
 
SESSION XXXV SCHEDULE
Sunday
SESSION XXXV: NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID, VERTEBRAL AND SUPRA-AORTIC TRUNK DISEASE (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D.
x
10:01 AM - 10:08 AM Factors Correlating With Restenosis After CEA: Can They Be Modified And Decrease Restenosis?
  Presenters(s): Glenn M. LaMuraglia, M.D.  
10:09 AM - 10:16 AM Natural History Of Carotid Artery Occlusion Contralateral To A CEA: It’s More Benign Than We Thought
  Presenters(s): Ali F. AbuRahma, M.D.  
10:17 AM - 10:24 AM Update On Results Of The CAPTURE Trial: What Does It Mean In The CAS Versus CEA Debate?
  Presenters(s): Ronald M. Fairman, M.D.  
10:25 AM - 10:32 AM Mini Skin Incision For CEA: A Safe Alternative To The Standard Approach: Indications And Contraindications
  Presenters(s): Enrico Ascher, M.D.  
10:33 AM - 10:40 AM Vertebral PTA And Stenting With Embolic Protection: How To Do It And Is It Necessary?
  Presenters(s): Karthikeshwar Kasirajan, M.D.  
10:41 AM - 10:48 AM Is Carotid Plaque Morphology Or Degree Of Stenosis More Important In Determining Prognosis Of An Individual Lesion In Terms Of Natural History; In Terms Of CAS?
  Presenters(s): Frans L. Moll, M.D., Ph.D.  
10:49 AM - 10:56 AM Intraoperative Imaging After CEA Does Not Improve Outcomes
  Presenters(s): Caron B. Rockman, M.D.  
10:57 AM - 11:04 AM Tips And Tricks For Managing Carotid Body Tumors
  Presenters(s): Wesley S. Moore, M.D.  
11:05 AM - 11:13 AM Panel Discussion
END OF SESSION XXXV
 
SESSION XXXVI SCHEDULE
Sunday
SESSION XXXVI: OTHER NEW DEVELOPMENTS IN STENTING OF THE CAROTID BIFURCATION AND SUPRA-AORTIC TRUNKS (6- AND 7-MINUTE TALKS)
Moderators:Juan C. Parodi, M.D.
x
11:14 AM - 11:21 AM When Should We Attempt To Open An Occluded Carotid Or Vertebral Artery? How Should It Be Done?
  Presenters(s): L. Nelson Hopkins, M.D.  
11:22 AM - 11:29 AM Transcervical Approach To CAS: 3-Year Follow-Up Of 100 Patients: Should It Be A Routine Approach?
  Presenters(s): Enrique Criado, M.D., F.A.C.S.  
11:30 AM - 11:37 AM Why Are Randomized Clinical Data The Only Way To Compare The Outcomes Of CAS With Those Of CEA? Do We Yet Have Any Valid Comparative Outcome Results From Anywhere In The Globe?
  Presenters(s): Robert W. Hobson II, M.D.  
11:38 AM - 11:44 AM Debate: Carotid Stenting Is Ready For General Acceptance And Usage
  Presenters(s): Mark H. Wholey, M.D.  
11:45 AM - 11:51 AM Debate: Carotid Stenting Is Not Ready For General Acceptance And Usage
  Presenters(s): Marc Bosiers, M.D.  
11:52 AM - 11:59 AM What Are The Real World Current Stroke And Death Rates For CEA Based On 2 Statewide Studies? How Do They Impact On The Present Role For CAS?
  Presenters(s): Bruce A. Perler, M.D., M.B.A.  
12:00 PM - 12:07 PM Ischemic Preconditioning To Facilitate Use Of Balloon Embolic Protection (With The PercuSurge Device) When It Is Poorly Tolerated During CAS: How Can This Work And Should The Principle Be Used More Generally?
  Presenters(s): Peter L. Faries, M.D.  
12:08 PM - 12:18 PM Panel Discussion
END OF SESSION XXXVI
 
SESSION XXXVII SCHEDULE
Sunday
SESSION XXXVII: UPDATES, NEW CONCEPTS, ADVANCES AND LATE BREAKING TRIALS (6-MINUTE TALKS)
Moderators:Dhiraj M. Shah, M.D. / John J. Ricotta, M.D.
x
12:19 PM - 12:26 PM Open Minimally Invasive Limb Salvage Procedures: A Less Morbid Approach
  Presenters(s): Peter F. Lawrence, M.D.  
12:27 PM - 12:33 PM How To Deal Surgically With A Heavily And Circumferentially Calcified (Porcelain) Aorta
  Presenters(s): Olivier A. Goëau-Brissonnière, M.D., Ph.D.  
12:34 PM - 12:40 PM What Effects Beyond Cholesterol Lowering Do Statin Drugs Have In Vascular Disease Patients?
  Presenters(s): Ralph G. DePalma, M.D.  
12:41 PM - 12:47 PM What’s New To Facilitate The Endovascular Treatment Of Traumatic Vascular Lesions?
  Presenters(s): Jan S. Brunkwall, M.D., Ph.D.  
12:48 PM - 12:54 PM Two-Year Results Of The European Superficial Femoral Artery Registry (ESFAR): Lessons Learned
  Presenters(s): Gerhard Hoffmann, M.D.  
12:55 PM - 1:01 PM Which Graft Is Best For Femorofemoral Bypass - Dacron Or PTFE? Based On Results Of A Randomized Trial In 198 Patients
  Presenters(s): Torben V. Schroeder, M.D., D.M.Sc.  
1:02 PM - 1:08 PM Isolated Limb Perfusion With Lytic Drugs Can Improve Limb Salvage After Acute Thromboembolism With Extensive Involvement Of Infrapopliteal Arteries
  Presenters(s): John F. Eidt, M.D.  
1:09 PM - 1:15 PM Influence Of Real-Time Hemodynamic Monitoring On The Outcome Of EVAR For Ruptured AAAs
  Presenters(s): J. Adam van der Vliet, M.D.  
1:16 PM - 1:22 PM Vascular Abnormalities In Patients With Neurofibromatosis: What The Vascular Surgeon Needs To Know
  Presenters(s): Peter Gloviczki, M.D.  
1:23 PM - 1:33 PM Panel Discussion
Moderator(s): Michael B. Silva, Jr., M.D. / Frank J. Veith, M.D.  
1:34 PM - 1:40 PM The Boomerang Device For Closure Of Arterial Punctures: Advantages And Limitations
  Presenters(s): Ali Amin, M.D., F.A.C.S., F.A.C.C., R.V.T.  
1:41 PM - 1:47 PM Is An Iliac Occlusion A Contraindication To EVAR? Techniques To Solve The Problem
  Presenters(s): William D. Jordan, Jr., M.D.  
1:48 PM - 1:54 PM New Methods And Adjuncts To Expand The Indications For EVAR
  Presenters(s): Jacques Bleyn, M.D.  
1:55 PM - 2:01 PM Chronic Spinal Cord Injury Increases Aortic Diameter And AAA Formation: What Is The Mechanism?
  Presenters(s): Ronald L. Dalman, M.D.  
2:02 PM - 2:08 PM Optimal Management Of Paget-Schroetter Syndrome: Does Lysis And Conservative Treatment Work And When Is Rib Resection And Stenting Indicated?
  Presenters(s): Matthew J. Eagleton, M.D.  
2:09 PM - 2:15 PM Complications And Outcomes Associated With Use Of Retrievable IVC Filters: Do The Devices Make A Difference Based On The Collected FDA Data?
  Presenters(s): Palma M. Shaw, M.D.  
2:16 PM - 2:22 PM Spontaneous Dissection Of The Abdominal Aorta: Clinical Presentation And Best Therapeutic Options: Open Surgical Versus Endovascular
  Presenters(s): Mark A. Farber, M.D.  
2:23 PM - 2:29 PM Late Breaking Development: Aptus AAA Endograft With Proximal Fixation Staples
  Presenters(s): David H. Deaton, M.D.  
2:30 PM - 2:40 PM Panel Discussion
2:40 PM - 2:45 PM Prize Drawing Raffle - $8.000 In Prizes. You Must Be Present To Win!
2:45 PM - 2:45 PM Symposium Ends.
SAVE-THE-DATE:
Wednesday, November 14 - Sunday, November 18, 2007.
SHERATON NEW YORK HOTEL & TOWERS.
PLEASE COME AGAIN.
END OF SESSION XXXVII